Patents by Inventor Thomas McCreery

Thomas McCreery has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240108770
    Abstract: Mobile decontamination systems and microwave assisted decontamination methods for decontaminating a variety of contaminated surfaces disposed external to the system. The systems and methods include treating the surfaces with benign chemical formulations followed by exposing to microwave irradiation for short periods of time to achieve at least 6-log reduction in biological contaminants including viruses and spores of B. anthracis, B. thuringiensis, and P. roqueforti. The formulations include a percarbonate and surfactant in water.
    Type: Application
    Filed: December 5, 2023
    Publication date: April 4, 2024
    Applicant: Zeteo Tech, Inc.
    Inventors: Thomas McCreery, Wayne A. Bryden, Emily Caton
  • Patent number: 11938243
    Abstract: Mobile decontamination systems and microwave assisted decontamination methods for decontaminating a variety of contaminated surfaces disposed external to the system are disclosed. The systems and methods comprise treating the surfaces with benign chemical formulations followed by exposing to microwave irradiation for short periods of time to achieve at least 6-log reduction in biological contaminants including viruses and spores of B. anthracis, B. thuringiensis, and P. roqueforti. The formulations comprise a percarbonate and surfactant in water.
    Type: Grant
    Filed: May 30, 2021
    Date of Patent: March 26, 2024
    Assignee: Zeteo Tech, Inc.
    Inventors: Thomas McCreery, Wayne A. Bryden, Emily Caton
  • Patent number: 11872322
    Abstract: Disclosed are microwave assisted methods and systems for decontaminating a variety of contaminated surfaces. The systems and methods comprise treating the surfaces with benign chemical formulations followed by exposing to microwave irradiation for short periods of time to achieve at least 6-log reduction in biological contaminants including spores of B. anthracis, B. thuringiensis, and P. roqueforti. Chemical formulations may comprise copper (II) chloride in water. The formulations may include a surfactant such as a polyethylene sorbitol ester surfactant.
    Type: Grant
    Filed: September 30, 2022
    Date of Patent: January 16, 2024
    Assignee: Zeteo Tech, Inc.
    Inventors: Thomas McCreery, Wayne A. Bryden
  • Publication number: 20230042863
    Abstract: Disclosed are microwave assisted methods and systems for decontaminating a variety of contaminated surfaces. The systems and methods comprise treating the surfaces with benign chemical formulations followed by exposing to microwave irradiation for short periods of time to achieve at least 6-log reduction in biological contaminants including spores of B. anthracis, B. thuringiensis, and P. roqueforti. Chemical formulations may comprise copper (II) chloride in water. The formulations may include a surfactant such as a polyethylene sorbitol ester surfactant.
    Type: Application
    Filed: September 30, 2022
    Publication date: February 9, 2023
    Applicant: Zeteo Tech, Inc.
    Inventors: Thomas McCreery, Wayne A. Bryden
  • Patent number: 11524087
    Abstract: Disclosed are microwave assisted methods and systems for decontaminating a variety of contaminated surfaces. The systems and methods comprise treating the surfaces with benign chemical formulations followed by exposing to microwave irradiation for short periods of time to achieve at least 6-log reduction in biological contaminants including spores of B. anthracis, B. thuringiensis, and P. roqueforti. Chemical formulations may comprise copper (II) chloride in water. The formulations may include a surfactant such as a polyethylene sorbitol ester surfactant.
    Type: Grant
    Filed: March 22, 2020
    Date of Patent: December 13, 2022
    Assignee: Zeteo Tech, Inc.
    Inventors: Thomas McCreery, Wayne A. Bryden
  • Publication number: 20220096685
    Abstract: Disclosed are microwave assisted methods and systems for decontaminating a variety of contaminated surfaces. The systems and methods comprise treating the surfaces with benign chemical formulations followed by exposing to microwave irradiation for short periods of time to achieve at least 6-log reduction in biological contaminants including spores of B. anthracis, B. thuringiensis, and P. roqueforti. Chemical formulations may comprise copper (II) chloride in water. The formulations may include a surfactant such as a polyethylene sorbitol ester surfactant.
    Type: Application
    Filed: March 22, 2020
    Publication date: March 31, 2022
    Applicant: Zeteo Tech, Inc.
    Inventors: Thomas McCreery, Wayne A. Bryden
  • Publication number: 20220039353
    Abstract: Devices and methods for enhanced hearing protection for animals are disclosed. Passive noise reduction components provide reduction of at least 20 dB to 30 dB in dogs using flexible soft muffs that are housed in a hearing protection sleeve. Active noise cancellation (ANC) features may also be used to increase noise reduction to about 40 dB over a large frequency range. The devices may employ passive noise reduction electronic bypass to measure and playback sounds at safe levels bypassing at least one of ANC and passive noise reduction. Communication components may be employed to provide for communication between the handler and the animal. The systems and methods may be used to protect the hearing and utility of military working dogs and hunting dogs.
    Type: Application
    Filed: September 15, 2019
    Publication date: February 10, 2022
    Applicant: Zeteo Tech, Inc.
    Inventors: Thomas McCreery, Michael McLoughlin, Evelyn McCreery, Noella A. Bryden, Stuart Collymore, Thomas Sager, Rebecca Baxter
  • Publication number: 20210290806
    Abstract: Mobile decontamination systems and microwave assisted decontamination methods for decontaminating a variety of contaminated surfaces disposed external to the system are disclosed. The systems and methods comprise treating the surfaces with benign chemical formulations followed by exposing to microwave irradiation for short periods of time to achieve at least 6-log reduction in biological contaminants including viruses and spores of B. anthracis, B. thuringiensis, and P. roqueforti. The formulations comprise a percarbonate and surfactant in water.
    Type: Application
    Filed: May 30, 2021
    Publication date: September 23, 2021
    Applicant: Zeteo Tech, Inc.
    Inventors: Thomas McCreery, Wayne A. Bryden, Emily Caton
  • Patent number: 7612033
    Abstract: The present invention is directed, inter alia, to a method for delivering a compound into a cell comprising administering to the cell the compound to be delivered, an organic halide, and/or a carrier. Ultrasound may also be applied, if desired.
    Type: Grant
    Filed: March 18, 2004
    Date of Patent: November 3, 2009
    Assignee: ImaRx Pharmaceutical Corp.
    Inventors: Evan C. Unger, Thomas McCreery
  • Publication number: 20070059248
    Abstract: The present invention describes, inter alia, oxygen delivery agents or blood substitutes comprising a fluorinated gas and a stabilizing material, uses for the oxygen delivery agents or blood substitutes, and apparatus for making and delivering the oxygen delivery agents or blood substitutes.
    Type: Application
    Filed: August 31, 2006
    Publication date: March 15, 2007
    Inventors: Evan Unger, Thomas McCreery, Yunqiu Wu
  • Patent number: 7105151
    Abstract: The present invention describes, inter alia, oxygen delivery agents or blood substitutes comprising a fluorinated gas and a stabilizing material, uses for the oxygen delivery agents or blood substitutes, and apparatus for making and delivering the oxygen delivery agents or blood substitutes.
    Type: Grant
    Filed: January 6, 2003
    Date of Patent: September 12, 2006
    Assignee: ImaRx Therapeutics, Inc.
    Inventors: Evan C. Unger, Thomas McCreery, Yunqiu Wu
  • Publication number: 20050080029
    Abstract: The present invention is directed, inter alia, to a method for delivering a compound into a cell comprising administering to the cell the compound to be delivered, an organic halide, and/or a carrier. Ultrasound may also be applied, if desired.
    Type: Application
    Filed: August 20, 2003
    Publication date: April 14, 2005
    Applicant: ImaRx Pharmaceutical Corporation
    Inventors: Evan Unger, Thomas McCreery
  • Publication number: 20050019266
    Abstract: Novel targeted compositions which may be used for diagnostic and therapeutic use. The compositions can be used in conjunction with diagnostic imaging, such as ultrasound, as well as therapeutic applications, such as therapeutic ultrasound.
    Type: Application
    Filed: January 23, 2003
    Publication date: January 27, 2005
    Inventors: Evan Unger, Thomas McCreery
  • Publication number: 20040176473
    Abstract: The present invention is directed, inter alia, to a method for delivering a compound into a cell comprising administering to the cell the compound to be delivered, an organic halide, and/or a carrier. Ultrasound may also be applied, if desired.
    Type: Application
    Filed: March 18, 2004
    Publication date: September 9, 2004
    Applicant: ImaRx Pharmaceutical Corp.
    Inventors: Evan C. Unger, Thomas McCreery
  • Patent number: 6743779
    Abstract: The present invention is directed, inter alia, to a method for delivering a compound into a cell comprising administering to the cell the compound to be delivered, an organic halide, and/or a carrier. Ultrasound may also be applied, if desired.
    Type: Grant
    Filed: April 29, 1997
    Date of Patent: June 1, 2004
    Assignee: ImaRx Pharmaceutical Corp.
    Inventors: Evan C. Unger, Thomas McCreery
  • Patent number: 6638767
    Abstract: The present invention is directed, inter alia, to a method for delivering a compound into a cell comprising administering to the cell the compound to be delivered, an organic halide, and/or a carrier. Ultrasound may also be applied, if desired.
    Type: Grant
    Filed: December 21, 2000
    Date of Patent: October 28, 2003
    Assignee: ImaRx Pharmaceutical Corporation
    Inventors: Evan C. Unger, Thomas McCreery
  • Patent number: 6627421
    Abstract: A system for applying energy to cells so as to elicit the formation of pores, to enhance transfection, and/or cell transformation, includes a computer, a plurality of acoustic probes for controllably applying acoustic energy to batches of cells, and a robot operatively for effecting relative movement between the probes and the batches of cells. Preferably, the acoustic energy comprises ultrasonic energy, which is applied in combination with optical or electrical energy to enhance the formation of pores in surface membranes of the cells.
    Type: Grant
    Filed: April 5, 2001
    Date of Patent: September 30, 2003
    Assignee: ImaRx Therapeutics, Inc.
    Inventors: Evan C. Unger, Yunqiu Wu, Thomas McCreery
  • Publication number: 20030120204
    Abstract: The present invention describes, inter alia, oxygen delivery agents or blood substitutes comprising a fluorinated gas and a stabilizing material, uses for the oxygen delivery agents or blood substitutes, and apparatus for making and delivering the oxygen delivery agents or blood substitutes.
    Type: Application
    Filed: January 6, 2003
    Publication date: June 26, 2003
    Inventors: Evan C. Unger, Thomas McCreery, Yunqiu Wu
  • Patent number: 6537246
    Abstract: The present invention describes, inter alia, oxygen delivery agents or blood substitutes comprising a fluorinated gas and a stabilizing material, uses for the oxygen delivery agents or blood substitutes, and apparatus for making and delivering the oxygen delivery agents or blood substitutes.
    Type: Grant
    Filed: June 18, 1997
    Date of Patent: March 25, 2003
    Assignee: IMARX Therapeutics, Inc.
    Inventors: Evan C. Unger, Thomas McCreery, Yunqiu Wu
  • Publication number: 20010031740
    Abstract: The present invention is directed, inter alia, to a method for delivering a compound into a cell comprising administering to the cell the compound to be delivered, an organic halide, and/or a carrier. Ultrasound may also be applied, if desired.
    Type: Application
    Filed: December 21, 2000
    Publication date: October 18, 2001
    Applicant: ImaRX Pharmaceutical Corporation
    Inventors: Evan C. Unger, Thomas McCreery